Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.
Bendell JC, Rosen LS, Mayer RJ, Goldman JW, Infante JR, Benedetti F, Lin D, Mizuguchi H, Zergebel C, Patel MR.
Bendell JC, et al. Among authors: zergebel c.
Cancer Chemother Pharmacol. 2015 Nov;76(5):925-32. doi: 10.1007/s00280-015-2850-4. Epub 2015 Sep 14.
Cancer Chemother Pharmacol. 2015.
PMID: 26370544
Free PMC article.
Clinical Trial.